about
Application of vibro-acoustography in prostate tissue imagingVibro-acoustography imaging of permanent prostate brachytherapy seeds in an excised human prostate--preliminary results and technical feasibility.In vitro comparative study of vibro-acoustography versus pulse-echo ultrasound in imaging permanent prostate brachytherapy seeds.Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility.A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyComparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'.Electronic and film portal images: a comparison of landmark visibility and review accuracy.Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer.The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer.Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy.Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience.Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer.Telemedicine in radiotherapy treatment planning: requirements and applications.Estimated limits of IMRT dose escalation using varied planning target volume margins.ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.Systolic and diastolic cardiac dysfunction early after the initiation of doxorubicin therapy: significance of gender and concurrent mediastinal radiation.Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer.Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device.Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression.Response to Drs Rogers, Hayes, and Demanes.Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.3D visualization, analysis, and treatment of the prostate using trans-urethral ultrasound.Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center.Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods.Prostate brachytherapy seed reconstruction using an adaptive grouping technique.A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update.Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.Seed localization and TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry.Examination of dosimetry accuracy as a function of seed detection rate in permanent prostate brachytherapy.Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem.Sternum First, Perhaps Pelvis Later.
P50
Q30443686-A856967F-7093-4F8B-818C-60575E197EADQ30483065-31F7B87B-C209-4C6B-A392-6A038B8D656CQ30483140-9C01B42B-6C68-4EFD-A784-94B542804B9EQ30486106-117E371B-E669-4D9C-B5D9-91A790A05A27Q33375063-17FC6D93-D41A-481E-AD03-7E337F9988BAQ34008499-9E38C22A-8629-4A30-869C-A3E1BAFD1821Q34875084-5D345C5C-8A57-45C4-877A-47ABD590ACDDQ35065405-C2EE24AB-7E80-4EF4-91ED-CC160BA9F737Q36398860-EB9C9563-CE29-4C1C-B32D-17FE8F9A1BFEQ36550767-0907ACE5-8502-4F1B-9F74-95B6735B768EQ36595228-F53C3032-FF35-4BBA-B6C2-FB73C370C6FEQ38005803-EAE4E21D-203E-4BD0-BD37-8DC9CA5745D9Q38089422-78F3A7A9-D249-4FD0-832B-423980EDA391Q38109403-DB7841D3-8DEA-463A-8CE0-457A77D65FB4Q38120925-19098B14-8552-4CB3-8192-ED44E780C783Q38170811-12639B92-B765-4E04-9388-5FBD835C395FQ39367376-5B30C4CD-5B10-4A43-84FC-41F36450D57AQ39532741-F28DAB97-44D5-4E45-BA64-33A26973AA03Q43742696-1081DCB0-6827-41F7-AE3B-77A07357C58CQ43784376-DDC04F89-8F15-4042-9B6F-F4512575716BQ44005286-3D53334C-46EF-464E-A252-59B62C6D93A2Q44124134-432CFEAC-2343-40A3-85B4-B5E433020C07Q44310536-70922BE4-3AA4-4FF6-9CFC-35B5D282B2E1Q44630129-F2EA52D4-80CA-4B1D-AFA6-53126F6C00B1Q44889792-5A8F5FE6-CB46-4A76-82CA-84F04C1C7199Q45257858-762EA2FC-EAC6-40CB-B88A-FEC8CE0256C6Q46875746-49C0A855-8A9C-487F-BC7F-2E7FD5BCE5D2Q47142647-B433AFF6-961E-4A5A-A029-F8E6BC6D4968Q47811564-67501C7D-C83E-4A38-B14D-BE0BF15CA5B3Q47873615-B1FC0C44-264E-4648-97DF-28628584F9D4Q48774788-CFCFB099-D2C0-4A5D-9397-E21CEAEBD926Q48898474-435ACF3A-AA84-436F-A425-F1380E7ADC88Q50895563-A5351E5F-C9AC-4C94-B23C-7F0FF90767C9Q50918203-F78B8381-FE85-4206-8388-BE76010494F6Q50965730-E829A280-C4F6-45AA-89B2-51F1FBD9BAA2Q51038003-A596252C-CEE7-4470-AE42-1B07A7593A2FQ51046242-F246AF1B-4619-4CE8-A3C8-43FC7E057012Q51326425-C0FEF476-A6BB-46A4-B887-1DBAF902687AQ51636480-33724DE6-3979-43BC-8850-EBF63D965CFDQ53108376-193F7FBA-D20B-42B9-AB0D-BA6927A715E1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian J Davis
@nl
Brian J Davis
@sl
Brian J. Davis
@en
Brian J. Davis
@es
type
label
Brian J Davis
@nl
Brian J Davis
@sl
Brian J. Davis
@en
Brian J. Davis
@es
prefLabel
Brian J Davis
@nl
Brian J Davis
@sl
Brian J. Davis
@en
Brian J. Davis
@es
P106
P108
P1153
7403922793
P1960
3-Rf22kAAAAJ
P21
P31
P496
0000-0002-8288-1096